Skip to content

The Relationship Between Psychedelic Use and Alcohol Use Disorder in a Nationally Representative Sample.

James M Zech, Jérémie Richard, Grant Jones

Journal of Psychoactive Drugs November 9, 2025 DOI: 10.1080/02791072.2025.2583967 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Observational cross-sectional study Randomized Peer reviewed
Sample size 139,524
Population Nationally representative sample of US adults
Topics Ketamine LSD MDMA Psilocybin Addiction
Keywords Aud Alcohol
Key findings Past-year LSD use was associated with lower odds of AUD and fewer AUD symptoms, whereas MDMA and ketamine use were not significantly associated with AUD.

Abstract

Psychedelic-assisted interventions are emerging as potential treatments for substance use disorders, including alcohol use disorder (AUD). While recent randomized controlled trials suggest efficacy for certain psychedelics and related compounds in treating AUD, the impact of naturalistic psychedelic use on problematic alcohol consumption remains underexplored. This study examines associations between psychedelic use and AUD in a nationally representative sample (N = 139,524). Logistic regression was used to examine the association between AUD and past-year use of LSD, MDMA, and ketamine, controlling for demographics and comorbid substance use. Past-year LSD use was significantly associated with lower odds of AUD (adjusted odds ratio [aOR] = 0.70, p = .006). However, use of MDMA (aOR = 1.17, p = .229) and ketamine (aOR = 1.28, p = .235) was not associated with AUD. In a quasi-Poisson regression analysis, past-year LSD use was found to be associated with 15.7% fewer AUD symptoms (IRR = 0.84, 95% CI: 0.72 - 0.98, p = .033), but neither past-year MDMA nor past-year ketamine use were significantly associated with AUD symptoms (MDMA: IRR = 0.97, 95% CI: 0.83 - 1.13, p = .731; ketamine: IRR = 1.21, 95% CI: 0.93 - 1.57, p = .139). Taken together, these findings indicate differential associations between specific psychedelics and AUD, with LSD use linked to a reduced risk of AUD. The results underscore the need for further research into the mechanisms by which LSD may influence alcohol use and AUD risk.

In the evidence

This study is part of the evidence base for a synthesis in the library. Here is how each one recorded it.

Comparable studies

Other cross-sectional and survey studies on LSD for addiction, most cited first.

Study Year Design Participants
User perceptions of the benefits and harms of hallucinogenic drug use: A web-based questionnaire study Users of hallucinogenic drugs who completed a web-based questionnaire 2010 Cross-sectional survey n = 600
Increased use of illicit drugs in a Dutch cluster headache population People with cluster headache in the Netherlands 2018 Cross-sectional study n = 756
Epidemiology of classic psychedelic substances: results from a Norwegian internet convenience sample Norwegian adults who have had a memorable experience after taking a classic psychedelic... 2023 Cross-sectional survey n = 770
Assessing The Readiness of Psychiatrists in Louisiana to Incorporate Psilocybin into Clinical Practice—Lessons Learned from a State Underrepresented in Clinical Psychedelic Research Registered psychiatrists in Louisiana 2025 Survey n = 49
Perceived outcomes of psychedelic microdosing as self-managed therapies for mental and substance use disorders. International online respondents with current or past experience of psychedelic... 2020 Cross-sectional survey n = 1,102

Explore topics

By condition and practice